Overview

HyperHAES Versus Placebo - Effect on Intracranial Pressure in SAH Patients

Status:
Completed
Trial end date:
2004-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether 7.2% NaCl in 6% hydroxyethyl starch will lower intracranial pressure (ICP) in SAH-patients with normal or moderately elevated ICP in a placebo controlled study, and to describe the haemodynamic effects.
Phase:
Phase 2
Details
Lead Sponsor:
Oslo University Hospital
Treatments:
Hydroxyethyl Starch Derivatives
Pharmaceutical Solutions